Biolife Solutions (BLFS) Operating Expenses (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Operating Expenses data on file, last reported at $17.5 million in Q1 2026.

• Operating Expenses for Q1 2026 came in at $17.5 million, up 14.18% year-over-year; the trailing twelve-month figure through Mar 2026 was $71.0 million (up 47.54% YoY), and the FY2025 annual result was $78.7 million, up 44.25% from the prior year.
• Operating Expenses rose to $17.5 million in Q1 2026 per BLFS's latest filing, from -$16.7 million in the prior quarter.
• Over five years, Operating Expenses peaked at $117.1 million in Q2 2022 and troughed at -$131.6 million in Q4 2022.
• A 5-year average of $17.4 million and a median of $21.8 million in 2024 frame the typical range for Operating Expenses.
• On a YoY basis, Operating Expenses climbed as much as 227.46% in 2022 and fell as far as 335.98% in 2022.
• A 5-year view of Operating Expenses shows it stood at -$131.6 million in 2022, then soared by 55.77% to -$58.2 million in 2023, then soared by 82.84% to -$10.0 million in 2024, then slumped by 66.83% to -$16.7 million in 2025, then jumped by 204.87% to $17.5 million in 2026.
• Business Quant data shows BLFS's Operating Expenses at $17.5 million in Q1 2026, -$16.7 million in Q4 2025, and $28.2 million in Q3 2025.